Eli Lilly's Breakthrough Weight-Loss Pill Soars Stock by 13% in Premarket Trading
Eli Lilly's stock jumps 13% after announcing positive phase 3 results for orforglipron, a groundbreaking weight-loss and diabetes pill, marking a first in medical innovation with i...